- /
- Supported exchanges
- / US
- / LNSR.NASDAQ
LENSAR Inc (LNSR NASDAQ) stock market data APIs
LENSAR Inc Financial Data Overview
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with LENSAR Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get LENSAR Inc data using free add-ons & libraries
Get LENSAR Inc Fundamental Data
LENSAR Inc Fundamental data includes:
- Net Revenue: 60 264 K
- EBITDA: -16 328 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LENSAR Inc News
New
LENSAR (LNSR) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, August 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Nicholas Curtis Interim Chief Financial Officer - Michael Rossi Investor R...
LENSAR Q2 Earnings Call Highlights
Key Points Interested in LENSAR, Inc.? Here are five stocks we like better. LENSAR's second-quarter revenue rose 18% to $16.5 million, driven by a 20% increase in recurring revenue to $13.7 million a...
LENSAR, Inc. Q2 2026 Earnings Call Summary
LENSAR, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Reset and Operational Performance Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest an...
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's ALC new platforms and lenses are gaining adoption. Dry eye momentum is likely to support growth in the upcoming quarters. However, adverse macroeconomic conditions and intense competition may ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.